Prestige Consumer Healthcare (PBH) Gross Margin Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) Gross Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 164.00 |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | -378.00 |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -397.00 |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | -173.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 156.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -92.00 |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 88.00 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.00 |
| Sep 30, 2025 | -16.00 |
| Jun 30, 2025 | 158.00 |
| Mar 31, 2025 | 253.00 |
| Dec 31, 2024 | -39.00 |
| Sep 30, 2024 | -43.00 |
| Jun 30, 2024 | -72.00 |
| Mar 31, 2024 | 102.00 |
| Dec 31, 2023 | 127.00 |
| Sep 30, 2023 | 23.00 |
| Jun 30, 2023 | -242.00 |
| Mar 31, 2023 | -198.00 |
| Dec 31, 2022 | -191.00 |
| Sep 30, 2022 | -144.00 |
| Jun 30, 2022 | -128.00 |
| Mar 31, 2022 | -188.00 |
| Dec 31, 2021 | -167.00 |
| Sep 30, 2021 | -89.00 |
| Jun 30, 2021 | 72.00 |
| Mar 31, 2021 | 36.00 |